Millennium Management’s X4 Pharmaceuticals XFOR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $148K | Buy |
78,061
+69,436
| +805% | +$132K | ﹤0.01% | 3769 |
|
|
2025
Q1 | $61.2K | Hold |
8,625
| – | – | ﹤0.01% | 3804 |
|
|
2024
Q4 | $190K | Sell |
8,625
-3,482
| -29% | -$76.6K | ﹤0.01% | 3680 |
|
|
2024
Q3 | $243K | Buy |
12,107
+660
| +6% | +$13.3K | ﹤0.01% | 3652 |
|
|
2024
Q2 | $199K | Buy |
11,447
+2,822
| +33% | +$49.1K | ﹤0.01% | 3571 |
|
|
2024
Q1 | $360K | Sell |
8,625
-46,852
| -84% | -$1.95M | ﹤0.01% | 3435 |
|
|
2023
Q4 | $1.4M | Sell |
55,477
-65,055
| -54% | -$1.64M | ﹤0.01% | 2646 |
|
|
2023
Q3 | $3.94M | Sell |
120,532
-61,188
| -34% | -$2M | ﹤0.01% | 2050 |
|
|
2023
Q2 | $10.6M | Buy |
181,720
+145,713
| +405% | +$8.48M | 0.01% | 1423 |
|
|
2023
Q1 | $940K | Sell |
36,007
-2,441
| -6% | -$63.7K | ﹤0.01% | 3083 |
|
|
2022
Q4 | $1.15M | Buy |
38,448
+34,683
| +921% | +$1.03M | ﹤0.01% | 3066 |
|
|
2022
Q3 | $193K | Buy |
3,765
+1,175
| +45% | +$60.2K | ﹤0.01% | 4455 |
|
|
2022
Q2 | $75K | Sell |
2,590
-10,875
| -81% | -$315K | ﹤0.01% | 4758 |
|
|
2022
Q1 | $707K | Buy |
13,465
+6,716
| +100% | +$353K | ﹤0.01% | 3840 |
|
|
2021
Q4 | $464K | Sell |
6,749
-2,163
| -24% | -$149K | ﹤0.01% | 4071 |
|
|
2021
Q3 | $1.41M | Sell |
8,912
-3,955
| -31% | -$628K | ﹤0.01% | 3340 |
|
|
2021
Q2 | $2.51M | Buy |
+12,867
| New | +$2.51M | ﹤0.01% | 2916 |
|
|
2020
Q2 | – | Sell |
-552
| Closed | -$165K | – | 3801 |
|
|
2020
Q1 | $165K | Sell |
552
-1,659
| -75% | -$496K | ﹤0.01% | 2781 |
|
|
2019
Q4 | $710K | Sell |
2,211
-4,077
| -65% | -$1.31M | ﹤0.01% | 2567 |
|
|
2019
Q3 | $2.4M | Buy |
6,288
+1,233
| +24% | +$470K | ﹤0.01% | 1907 |
|
|
2019
Q2 | $2.28M | Buy |
+5,055
| New | +$2.28M | ﹤0.01% | 1953 |
|
|
2018
Q1 | – | Sell |
-130
| Closed | -$299K | – | 3811 |
|
|
2017
Q4 | $299K | Buy |
+130
| New | +$299K | ﹤0.01% | 3120 |
|